S 1165, the Reentry Act of 2023, allows Medicaid coverage for incarcerated individuals during the 30 days preceding their release from prison or jail. This directly affects people transitioning from correctional facilities back into communities by connecting them to healthcare immediately after release. The bill amends Medicaid law to remove a barrier preventing coverage during this critical period. It also requires a report within 18 months analyzing correctional healthcare standards, the number of eligible individuals, and discharge processes to support better health transitions.
The Veterans Equal Access Act (HR 2431) allows Department of Veterans Affairs (VA) health care providers to give recommendations and opinions to veterans about participating in state-legal marijuana programs. It directly affects veterans living in states, the District of Columbia, Puerto Rico, U.S. territories, or federally recognized tribes where marijuana is permitted under state law. The bill requires the VA Secretary to authorize VA physicians and staff to provide these recommendations, complete related forms, and override any conflicting federal restrictions that previously prohibited such advice. This change enables veterans to receive guidance from VA providers regarding state marijuana programs without fear of VA disciplinary action.
The Panama Canal Zone Veterans Act of 2023 creates a presumption that veterans who served in the Panama Canal Zone between 1958 and 1999 (or until the last military member left) and developed specific illnesses are automatically eligible for VA benefits without needing to prove a direct link between their service and the condition. It lists 16 illnesses, including prostate cancer, lung cancer, diabetes, Parkinson's disease, and several other cancers, as qualifying for this presumption due to presumed exposure to herbicides like Agent Orange during service. The VA will use regulations based on medical evidence to determine which illnesses qualify under this provision. This change directly affects veterans who served in the Panama Canal Zone during the covered period and later developed one of the listed conditions.
The Coastal Seaweed Farm Act of 2023 requires the Secretaries of Agriculture and Commerce to conduct a two-year study on coastal seaweed farming's environmental, economic, and community impacts, including best practices for sustainability, ecosystem protection, and consultation with Indigenous groups. It establishes an Indigenous Seaweed Farming Fund to provide grants for seaweed farming projects by federally recognized Tribes, Native entities, and Indigenous communities, with restrictions to prevent harm to commercial fisheries. The bill also mandates regulations to ensure seaweed farming operations maximize marine ecosystem benefits while minimizing adverse effects, and allocates $3 million annually for the study and regulations, plus $20 million annually for the grant program. This legislation directly affects Tribal communities, coastal ecosystems, and future seaweed farming operations through concrete policy requirements.
Freedom to Decide Act This concurrent resolution expresses the sense of Congress to (1) affirm that federal law authorizes the distribution of medication abortion, including by mail, as stated in a 2022 Department of Justice memorandum; and (2) condemn restrictions on the access and coverage of reproductive health care, including medication abortion.
HR 2630, the Safe Step Act, requires group health plans and health insurance issuers to establish a clear, transparent process for patients or their doctors to request exceptions to medication step therapy protocols. These protocols typically force patients to try cheaper drugs first before covering more expensive alternatives. The bill mandates that plans must approve exceptions when prior treatments failed, delay would cause serious harm, a treatment is unsafe, or a patient is stable on a previously approved drug, with strict 72-hour (or 24-hour in emergencies) decision timelines. It also requires plans to publish the exception process online and limit documentation requests to only necessary medical information. This law directly affects health insurers, employers offering health plans, and patients using step therapy for prescription drugs.
HR 2402, the Alan Reinstein Ban Asbestos Now Act of 2023, bans the manufacture, processing, use, and sale of commercial asbestos (including specific types like chrysotile and crocidolite) in the U.S. starting one year after enactment, with key exceptions. It allows the chlor-alkali industry to continue using asbestos for diaphragm manufacturing until two years after enactment and permits limited national security exemptions for up to three years with public disclosure. The bill also requires the EPA and HHS to create public education resources about asbestos health risks and mitigation options. This directly affects manufacturers, distributors, and users of commercial asbestos products, excluding asbestos present only as an impurity.
Resident Physician Shortage Reduction Act of 2023 This bill increases the number of residency positions eligible for graduate medical education payments under Medicare for qualifying hospitals, including hospitals in rural areas and health professional shortage areas. Current law provides for an increase of up to 200 positions per fiscal year beginning in FY2023, with a total increase of 1,000 positions; each hospital may receive up to 25 additional positions. Current law also provides for an additional increase of up to 200 positions for FY2026, with at least 100 of these positions for psychiatry or related specialties; each hospital may receive up to 10 additional positions. The bill provides for an additional increase of 2,000 positions per fiscal year from FY2025-FY2031; during this period, each hospital may receive up to 75 additional positions in total under the bill and current law. Additionally, one-third of the positions that are made available under the bill must be allocated to hospitals that are already operating above applicable resident limits. The bill also requires the Government Accountability Office to report on strategies to increase the diversity of the health professional workforce, including with respect to representation from rural, low-income, and minority communities.
The Women's Health Protection Act of 2023 would protect access to abortion services by prohibiting states from imposing restrictions that are more burdensome than those for comparable medical procedures. The bill would ensure people can obtain abortion services before fetal viability without unnecessary limitations like mandatory waiting periods or biased counseling, and after viability when necessary to protect the patient's life or health. It would preempt state laws that conflict with these protections and allow for civil enforcement actions to challenge restrictive state laws. This bill directly affects people seeking abortion services (including transgender and nonbinary individuals who can become pregnant), health care providers, and states that have implemented abortion restrictions.
HR 2532, the Women in NCAA Sports Act, establishes a 16-member Commission to study and compare how the NCAA treats men’s and women’s sports programs. The Commission will examine NCAA operations - including tournament venues, budgets, media contracts, and policies - to identify disparities in treatment across all sports and student-athlete programs. After 18 months, it must submit a report to Congress with findings and recommendations for improving fairness, while avoiding any review of athlete eligibility. The bill directly affects NCAA operations and requires Congress to consider the Commission’s findings for potential policy changes.
This bill establishes a federal grant program to fund state and tribal governments in implementing Next Generation 9-1-1 systems, which upgrade emergency call systems to handle text, video, and data alongside voice calls. It requires grantees to develop coordinated implementation plans emphasizing cybersecurity, interoperability, rural/urban equity, and sustainable funding, with funds covering training, infrastructure, and public outreach. The bill mandates an annual report to Congress, creates a cybersecurity center for threat coordination, and forms an advisory board of public safety professionals to guide implementation. It directly affects state/local emergency communications centers, public safety agencies, and the 9-1-1 systems used by the public during emergencies.
S 1098, the Global Health, Empowerment and Rights Act, changes U.S. aid rules for foreign nongovernmental organizations (NGOs) receiving funding under the Foreign Assistance Act. It removes eligibility barriers for these NGOs if they provide health services (like counseling) using their own funds, as long as those services comply with local laws and would be legal in the U.S. It also eliminates extra restrictions on how foreign NGOs can use non-U.S. government funds for advocacy or lobbying, making these rules the same as those applied to U.S. NGOs receiving similar aid. This directly affects foreign health-focused NGOs working in international development and rights advocacy.
